Exhibit 1

JOINT FILING AGREEMENT

The undersigned hereby agree that the Amendment No. 2 to Schedule 13D, dated May 4, 2023, with respect to the common stock of BiomX Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Each of the undersigned agrees to be responsible for the timely filing of this Statement, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the 8^th day of May 2023.

	By:	/s/ Carl L. Gordon
		Carl L. Gordon

	By:	/s/ Erez Chimovits
		Erez Chimovits

	ORBIMED ISRAEL GP LTD.

	By:	/s/ Carl L. Gordon
		Name: Carl L. Gordon
		Title: Director

	ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP

	By:	ORBIMED ISRAEL GP LTD., its general partner

	By:	/s/ Carl L. Gordon
		Name: Carl L. Gordon
		Title: Director of OrbiMed Israel GP Ltd.